BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 10, 2008
View Archived Issues
Nestle sells 25% minority stake in Alcon to Novartis
Read More
Similar cardiac event rates in diabetics, non-diabetics given TAXUS Express stent
Read More
PROTECT study shows improved dyspnea, preserved renal function with rolofylline
Read More
Pilot study shows potential of beraprost in pulmonary arterial hypertension
Read More
Galderma completes an all cash tender offer for CollaGenex
Read More
Stable disease noted in prostate cancer patients treated with TroVax
Read More
GW reports preliminary phase III Sativex results in MS neuropathic pain
Read More
MAP reports positive phase IIa results for combination therapy in asthmatic adults
Read More
MediciNova reports results from two-year phase II MN-166 trial in MS
Read More
TaiGen presents positive data from phase II nemonoxacin study
Read More
Epix expands collaboration agreement with Cystic Fibrosis Foundation Therapeutics
Read More
Hemispherx accelerates Ampligen as an adjuvant for avian influenza and HIV vaccines
Read More
GW-406381 effective in phase II acute migraine study
Read More
Endo withdraws sNDA for Frova in menstrual migraine and returns rights to Chronogesic
Read More
Targeted Genetics acquires full exclusive rights to HD program from Sirna Therapeutics
Read More
Microbia changes name to Ironwood Pharmaceuticals
Read More
Biovitrum reports promising results from phase II study of BVT-115959 in neuropathic pain
Read More
Bristol-Myers Squibb selects Isis antisense drug targeting PCSK9 as development candidate
Read More
Anesiva initiates phase III clinical trial of Adlea in postsurgical pain following knee surgery
Read More
Arena initiates screening in phase IIb clinical trial of APD-125 in primary insomnia
Read More
Protox initiates phase II PRX-302 study in benign prostatic hyperplasia
Read More
Novel antiviral compounds disclosed in recent Coley patent
Read More
Wex commences phase III Tectin trial for cancer pain
Read More
Recent Ranbaxy patent reports novel therapeutic agents for urinary incontinence
Read More
New therapeutic agents for respiratory disorders described in recent patent literature
Read More